23 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 23 of 23 clinical reviews.
Evidence-based guide to the interaction between Lantus (insulin glargine) and progesterone hormone replacement therapy, including mechanism, evidence quality, monitoring, and what remains unverified.
Can you take Lantus with testosterone? Learn about the insulin glargine and testosterone interaction, including effects on blood glucose, polycythemia risk, monitoring protocols, and dose adjustments.
A clinical review of the insulin glargine (Lantus) and acetaminophen interaction, covering pharmacodynamic effects, CGM interference, hepatic considerations, monitoring protocols, and patient counseling.
A detailed clinical review of the insulin glargine (Lantus) and apixaban interaction, covering pharmacokinetic and pharmacodynamic mechanisms, bleeding and hypoglycemia risk, monitoring parameters, and patient counseling points.
Clinical guide to the insulin glargine (Lantus) and atorvastatin interaction, including mechanism, severity, monitoring parameters, and dose adjustment recommendations.
A guide to the pharmacodynamic interaction between insulin glargine (Lantus) and benzodiazepines, covering mechanism, hypoglycemia risk, monitoring parameters, dose considerations, and patient counseling points.
Is it safe to take insulin glargine (Lantus) with clopidogrel (Plavix)? A clinical review of the pharmacokinetic and pharmacodynamic interaction profile, monitoring recommendations, and dose-adjustment guidance.
A clinical guide to the interaction between insulin glargine (Lantus) and diphenhydramine (Benadryl), covering mechanism, severity, monitoring, and dose adjustments.
A guide to the pharmacodynamic interaction between insulin glargine (Lantus) and estradiol HRT, covering mechanism, blood glucose monitoring, dose adjustment, and patient counseling.
Is it safe to take insulin glargine (Lantus) with finasteride? A review of the pharmacologic pathways involved, what is and is not established about a metabolic interaction, and practical monitoring guidance.
Clinical guide to the insulin glargine (Lantus) and levothyroxine interaction, covering mechanism, severity, monitoring parameters, dose adjustment, and patient counseling.
Evidence-based guide to the insulin glargine (Lantus) and metformin drug interaction, including pharmacodynamic synergy, hypoglycemia risk, dose adjustment protocols, and monitoring guidelines for type 2 diabetes.
Clinical guide to the insulin glargine and NSAID drug interaction, covering hypoglycemia risk, renal effects, monitoring protocols, and dose adjustment strategies.
Clinical guide to the drug interaction between insulin glargine (Lantus) and opioids including oxycodone, hydrocodone, and tramadol. Covers hypoglycemia risk, monitoring, and dose adjustment.
Clinical review of the interaction between insulin glargine (Lantus) and proton pump inhibitors (omeprazole, pantoprazole), covering mechanism, severity, monitoring, and dose adjustment.
Evidence-based guide to the insulin glargine (Lantus) and prednisone interaction: mechanism, severity, monitoring, and what remains uncertain, for editorial and clinical review.
A clinical guide to the insulin glargine (Lantus) and pregabalin interaction, covering mechanism, severity, monitoring parameters, dose adjustments, and patient counseling.
Evidence-based review of the insulin glargine (Lantus) and rivaroxaban drug interaction, including mechanism, clinical significance, monitoring parameters, and dose adjustment guidance.
Can you take Lantus (insulin glargine) with rosuvastatin? A guide covering the pharmacokinetic and pharmacodynamic interaction profile, monitoring protocols, and dose-adjustment considerations.
A clinical guide to the insulin glargine (Lantus) and simvastatin drug interaction, covering mechanism, severity, monitoring, and what remains unverified in the underlying evidence.
Clinical guide to the insulin glargine (Lantus) and SSRI interaction. Covers hypoglycemia risk, monitoring protocols, dose adjustment, and patient counseling for sertraline and escitalopram use with basal insulin.
Clinical guide to the insulin glargine (Lantus) and trazodone drug interaction, including mechanism, severity, monitoring parameters, and what remains unverified.
A guide to the insulin glargine and warfarin drug interaction, covering mechanism, INR monitoring, dose adjustments, and patient safety counseling.